NCI Inc (NCIT) 14.08 $NCIT CGI Group Receives Medical IT

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
NCI Inc (NCIT) 14.08 $NCIT

CGI Group Receives Medical IT Support Contract from DISA
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 9:56AM CDT
CGI Group Inc. (GIB) was recently awarded a task order to provide operational and interoperability testing under the U.S. Defense Information Systems Agency (DISA) Test and Evaluation (T&E) Mission Support Services (MSS) contract.
EBIX: 52.12 (+2.98), KEYW: 10.59 (-0.38), NCIT: 14.08 (+0.22), GIB: 43.00 (+0.14)

NCI Awarded Contract to Continue Big Data Implementation at IRS
BusinessWire - Wed May 25, 7:05AM CDT
NCI, Inc. (NASDAQ: NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today it was awarded a task order valued at $4.9 million with the Internal Revenue Service (IRS) for architecture and engineering services to streamline data processing using big data practices and technologies. The sole-source award is for a 12-month period and falls under NCI's TIPSS-4 contract.
NCIT: 14.08 (+0.22)

Scientific Games (SGMS) Incurs Loss Again, Q1 Sales Lag
Zacks Equity Research - Zacks Investment Research - Fri May 06, 9:16AM CDT
Scientific Games Corp (SGMS) reported first-quarter 2016 loss of $1.07, comparing unfavorably with the Zacks Consensus Estimate of a loss of $1.01.
SGMS: 9.71 (+0.59), CSGS: 41.43 (+0.47), LOGM: 62.78 (-0.17), NCIT: 14.08 (+0.22)

NCI tops Street 1Q forecasts
Automated Insights - Wed Apr 27, 4:27PM CDT
RESTON, Va. (AP) _ NCI Inc. (NCIT) on Wednesday reported first-quarter profit of $3.3 million.
NCIT: 14.08 (+0.22)

NCI Reports First Quarter 2016 Financial and Operating Results
BusinessWire - Wed Apr 27, 3:06PM CDT
--EPS of $0.24 exceeds high end of guidance; and
NCIT: 14.08 (+0.22)

NCI Schedules First Quarter 2016 Earnings Conference Call for April 27, 2016
BusinessWire - Fri Apr 15, 3:37PM CDT
NCI, Inc. (NASDAQ: NCIT) announced today it will issue its first quarter 2016 financial results for the period ended March 31, 2016, after the market closes on Wednesday, April 27, 2016. Management will discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern time.
NCIT: 14.08 (+0.22)

CACI Scores Big on Health IT Contract for Veterans Affairs
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 2:45PM CDT
CACI International Inc. (CACI) revealed that it has secured a prime position on a $22.3 billion multiple-award contract, under which it will provide information technology services and solutions to the Department of Veterans Affairs.
CACI: 90.72 (-1.14), EBIX: 52.12 (+2.98), NCIT: 14.08 (+0.22), GIB: 43.00 (+0.14)

NCI Wins Position on Innovative GSA Agile Services BPA
BusinessWire - Wed Apr 06, 7:05AM CDT
NCI, Inc. (NASDAQ: NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today it was awarded a five-year, multiple-award blanket purchase agreement (BPA) with a ceiling value of $25 million through the General Services Administration (GSA) and its 18F technology consulting group to provide agile services. The award is subject to the terms and conditions of the company's GSA Schedule 70. GSA's Assisted Acquisition Services office will manage the post-award task orders.
NCIT: 14.08 (+0.22)

CACI to Provide Geospatial Support Services to USSOCOM
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 2:25PM CDT
CACI International Inc. (CACI) recently secured a five-year (one base plus four option years) contract, worth $180 million from the U.S. Special Operations Command (USSOCOM).
CACI: 90.72 (-1.14), EBIX: 52.12 (+2.98), NCIT: 14.08 (+0.22), GIB: 43.00 (+0.14)

NCI (NCIT) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:17AM CDT
NCI, Inc. (NCIT) has been struggling lately, but the selling pressure may be coming to an end soon
NCIT: 14.08 (+0.22)

3 Reasons Why NCI, Inc. (NCIT) is a Great Value Stock
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 7:48AM CDT
NCI, Inc. is a great value stock to watch out for given its impressive Zacks rank and value scores.
NCIT: 14.08 (+0.22)

CSG Systems International (CSGS) Crumbles: Stock Plunges by 10.8%
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 7:48AM CST
CSG Systems International's shares dropped 11% yesterday , reversing the recent uptrend as the stock was up around 10% in the past one-month time frame till Mar 9.
CSGS: 41.43 (+0.47), NCIT: 14.08 (+0.22)

NCI beats Street 4Q forecasts
Automated Insights - Wed Feb 10, 4:45PM CST
RESTON, Va. (AP) _ NCI Inc. (NCIT) on Wednesday reported fourth-quarter earnings of $3.6 million.
NCIT: 14.08 (+0.22)

NCI Reports Fourth Quarter and Fiscal Year 2015 Financial and Operating Results
BusinessWire - Wed Feb 10, 3:05PM CST
--Company reports fourth-quarter bookings of $130 million, or 1.5 times revenue; fiscal year 2015 bookings of $441 million, or 1.3 times revenue;
NCIT: 14.08 (+0.22)

NCI Down 20.8% Since SmarTrend Downtrend Call (NCIT)
Comtex SmarTrend(R) - Wed Feb 10, 9:38AM CST
SmarTrend identified a Downtrend for NCI (NASDAQ:NCIT) on December 17th, 2015 at $14.58. In approximately 2 months, NCI has returned 20.78% as of today's recent price of $11.55.
NCIT: 14.08 (+0.22)

BUYINS.NET: NCIT Expected To Be Up After Next Earnings Release
M2 - Wed Feb 10, 6:15AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, February 10th 2016 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. NCI Inc (NASDAQ:NCIT) are all expected to be Up After their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com . The following stocks are expected to go Up After earnings are released Wednesday:
NCIT: 14.08 (+0.22)

NCI Shares Down 15.3% Since SmarTrend's Sell Call (NCIT)
Comtex SmarTrend(R) - Tue Feb 02, 2:25PM CST
SmarTrend identified a Downtrend for NCI (NASDAQ:NCIT) on December 17th, 2015 at $14.58. In approximately 2 months, NCI has returned 15.29% as of today's recent price of $12.35.
NCIT: 14.08 (+0.22)

NCI Schedules Fourth Quarter and Fiscal Year 2015 Earnings Conference Call for February 10, 2016
BusinessWire - Fri Jan 22, 8:29AM CST
NCI, Inc. (NASDAQ: NCIT) announced today it will issue its fourth quarter and fiscal year 2015 financial results for the period ended December 31, 2015, after the market closes on Wednesday, February 10, 2016. Management will discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern Time.
NCIT: 14.08 (+0.22)

NCI ON Team Awarded Contract Supporting U.S. Air Force
BusinessWire - Wed Jan 20, 7:05AM CST
NCI, Inc. (NASDAQ:NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today it was awarded a firm-fixed-price and time-and-materials subcontract valued at $9 million to provide IT support services to the U.S. Air Force Research Laboratory (AFRL) Rome Research Site (RRS) in Rome, New York. The award continues the support provided to RRS by NCI under a subcontract with CDO Technologies Inc. on its NETCENTS-2 contract. The contract consists of a one-year base period and four one-year option periods.
NCIT: 14.08 (+0.22)

BUYINS.NET: NPO, NCIT, AEGR, TLT, ECT, TGH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jan 11, 6:48AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EnPro Industries Inc (NYSE:NPO), NCI Inc (NASDAQ:NCIT), Aegerion Pharmaceuticals Inc (NASDAQ:AEGR), iShares Barclays 20+ Year Treasury Bond Fund (NYSE:TLT), ECA MARCELLUS TRUST I (NYSE:ECT), Textainer Group Holdings Ltd (NYSE:TGH) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ECT: 1.98 (+0.01), AEGR: 1.62 (-0.05), TGH: 12.06 (+0.76), NCIT: 14.08 (+0.22), TLT: 142.34 (-1.26), NPO: 46.63 (+0.81)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading